CEO Insights Magazine

From charting the future roadmap of the firm to steering it towards the end goals, a CEO plays a pivotal role in a business. Dr. Sung Ho Wang, at the helm of Nemesis, exemplifies this leadership prowess. With a background in engineering, he envisions semiconductor solutions for societal impact. Wang's short-term focus on market expertise, medium-term goal of embracing challenges through an IPO, and long-term vision to empower Korean semiconductor startups underscore his commitment to industry transformation. His leadership philosophy encourages individual perspectives and unwavering persistence, echoing the mantra, ‘You, never never give up!’ Dr. Sung Ho Wang's strategic guidance and commitment to positive challenges exemplify his dedication to a thriving future. Let’s hear more from him in this one on one interaction.

Can you provide a brief overview of your professional journey and share what inspires your daily routines?

Running a business can be challenging, leading to moments of reduced motivation and diminished enthusiasm. Personally, I draw inspiration from a specific mission: crafting a success narrative for a semiconductor design startup in Korea. This success story isn't just about achieving financial success but serves as a model benefiting all stakeholders, employees, and society, aiming for a successful exit— an accomplishment not commonly seen in Korea where profits typically favor major shareholders.

Tell us about Nemesis as a company and elaborate on its standing within the market.

Historically, there was limited demand for semiconductors in biomedicine due to the small quantities involved. However, the rise of digital healthcare has spurred a rapid increase in demand, emphasizing the importance of semiconductors. Large global semiconductor companies lack support for a customer's dedicated chip, crucial for competitiveness. With expertise in semiconductors and biotechnology, Nemesis provides customization services, positioning itself as a developer and supplier of specialized bio signal processing chips, addressing the evolving needs of the biomedical semiconductor market.

In your role as the CEO, what considerations do you factor in when formulating impactful corporate growth strategies?

We employ three growth strategies. Firstly, we prioritize securing customer loyalty by creating customized chips and maintaining a consistent supply, fostering enduring relationships, crucial in the stable bio healthcare sector.

Secondly, we aim to broaden our reach by expanding application areas. Currently focused on glucose, electrocardiogram, and image monitoring, our future plans include venturing into EEG and multi-modal sensing, monitoring diverse vital signs concurrently due to the numerous biomarkers in the body.

Lastly, our long-term vision involves market positioning as experts. While achieving academic milestones in bio-signal processing semiconductor technology, our strategy is to evolve into a recognized expert group in the field.

What is the process of building the team, and how do you cultivate an environment of innovation within it?

The team is organized into four key divisions. The primary is the Research and Development (R&D) team, dedicated to novel research persuits and the development of innovative solutions. Other crucial teams are product manufacturing, marketing and sales, and administrative support, all collaborating seamlessly to realize our strategic objectives. In my perspective, innovation thrives on autonomy, fostered by a culture that embraces failure. In this context, I find NASA's mantra, 'Failure is not an option’, to be significant. However, it is crucial to differentiate between beneficial failures stemming from challenges and detrimental failures resulting from recurring simple mistakes. Embracing and learning from the former while avoiding the latter is key to cultivating a culture of innovation.

Share insights into your leadership approach. What principles or methodologies guide your leadership style?

My leadership aspiration is to be a front-line leader, actively involved rather than one who merely issues directives from a distant position. This approach, while challenging, holds significance for me. As a leader, it is essential to articulate a clear vision, and I delineate this vision into three key aspects. First, we must communicate what our company does and the underlying reasons behind our actions. Following this, we need to share the company's goals, whether they pertain to revenue targets after three years, market positioning, or an initial public offering (IPO). Lastly, it is crucial to establish specific rewards for each employee upon achieving these goals. I firmly believe that clearly defined incentives, as opposed to vague ones, are integral in providing meaningful motivation.

What is the future destination you are headed towards, and what advice do you offer to budding leaders navigating new opportunities in this domain?

In the short term, our goal is market expertise, followed by tackling more substantial challenges through an IPO in the medium term. Long term, we aspire to create success stories for startups in the Korean semiconductor industry, encouraging youth participation.

Advice for budding leaders would be firstly, encour­age individual perspectives; my initial engineering goal was affordable, high-quality products. As a busi­nessman, I follow the adage, 'What is helpful to me is helpful to others,' fostering true win-win scenarios. Secondly, persistence is key; quoting Prime Minister Churchill, 'You, never never give up!' Even in difficulty, steadfastness can unveil small opportunities. Em­bracing positive challenges collectively contributes to building a happier society.

Dr. Sung Ho Wang, CEO, Nemesis

Dr. Sung Ho Wang, CEO of Nemesis, is a visionary leader navigating the forefront of semiconductor innovation. With a background in engineering, he champions affordable solutions for societal impact. His commitment to market expertise, coupled with a long-term vision for startup success, reflects a dedication to fostering positive change in the industry.